Pharma & Biotech

The pharmaceutical giant Pfizer is navigating a challenging start to 2026, caught in a crossfire of financial, regulatory, and competitive...

Intellia Therapeutics finds itself in a challenging phase as regulatory delays for a key drug candidate trigger a wave of...

Lexicon Pharmaceuticals finds itself at a pivotal juncture in its evolution into a research-driven biopharma entity. The company's near-term trajectory...

A prominent analyst at investment bank H.C. Wainwright has reiterated a bullish stance on Viking Therapeutics, setting a price target...

Mersana Therapeutics stock continues to trade within a consolidation pattern as investors assess the pending acquisition by Day One Biopharmaceuticals....

ClearPoint Neuro Inc. is currently experiencing positive momentum, driven by significant progress from a key biotechnology partner and the strategic...

Shares of Tandem Diabetes Care are experiencing a period of consolidation following a robust weekly gain. The stock presents a...

In a decisive move aligning leadership incentives with corporate goals, Ocugen, Inc. has established a substantial performance-based equity award for...

BioNTech has completed its takeover of CureVac, a move that solidifies its commanding position within Germany's mRNA therapeutics landscape. By...

Shares of InnoCan Pharma are staging a technical recovery in early European trading, gaining approximately 6% after a recent sell-off....